Medicine by Design-funded foundational technology grows into biotech success story: Notch Therapeutics closes an $85 million Series A financing

Medicine by Design-funded research program that aims to generate next-generation immunomodulation therapies has seeded a Canadian biotechnology success story with the closing of an $85-million (U.S.) Series A financing.